世界の睡眠時無呼吸症候群治療市場動向(~2020)

◆英語タイトル:Global Sleep Apnea Market Outlook 2020
◆商品コード:RNCS60103
◆発行会社(リサーチ会社):RNCOS
◆発行日:2016年1月
◆ページ数:75
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD1,500 ⇒換算¥165,000見積依頼/購入/質問フォーム
Multi-UserUSD2,000 ⇒換算¥220,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はRNCOS社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。RNCOS社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートでは、世界の睡眠時無呼吸症候群治療市場について調査・分析し、市場概要、市場動向、市場展望、世界の睡眠時無呼吸症候群治療市場規模、地域別市場規模、種類別市場規模、用途別市場規模、主要企業分析などの情報をお届けいたします。

・世界の睡眠時無呼吸症候群治療市場:市場概要
・世界の睡眠時無呼吸症候群治療市場:市場動向
・世界の睡眠時無呼吸症候群治療市場:市場展望
・世界の睡眠時無呼吸症候群治療市場:種類別市場規模
・世界の睡眠時無呼吸症候群治療市場:用途別市場規模
・世界の睡眠時無呼吸症候群治療市場:地域別市場規模
・世界の睡眠時無呼吸症候群治療市場:主要企業分析

※上記の和訳は最新内容ではない場合があります。
【レポートの概要】

Sleep apnea is a common disorder that occurs when a person’s breathing is interrupted during sleep. Sleep apnea is a chronic condition and often largely goes undiagnosed. Sleep apnea can be further differentiated into three types: obstructive sleep apnea, central sleep apnea, and complex/mixed sleep apnea. Obstructive sleep apnea occurs when the muscles relax during sleep, causing soft tissue in the back of the throat to collapse and block the upper airway. It is also the most common type of sleep apnea seen in people. An untreated sleep apnea can increase the risk of high blood pressure, heart attack, stroke, obesity, and diabetes. It also increases the risk of, or worsen, heart failure and the chances of having work-related or driving accidents.

According to a new analysis from RNCOS in “Global Sleep Apnea Market Outlook 2020” report, the global sleep apnea therapeutic devices market is anticipated to grow at a CAGR of 7.5% during the forecast period (2015-2020). The market growth is expected mainly due to the growing incidences of sleep-related breathing disorders, increasing awareness about sleep apnea coupled with the rising incidences of obesity.

According to the analysis by RNCOS, conventional Positive Airway Pressure (PAP) devices continue to dominate the market in terms of the therapeutic devices used for the treatment of sleep apnea; however it is the oral appliances segment that is expected to witness the maximum growth in the coming years. This high growth is likely to be driven by the fact that oral appliancesare small and discreet and easily potable as compared to the conventional devices.

Also, in terms of application of the devices, obstructive sleep apnea is most commonly observed amongst all the three types of sleep apnea; however, central sleep apnea has an increasing incidence in patients with heart diseases. In terms of geography, North America is the largest market forsleep apnea therapeutic devices market, but it is the Asia Pacific market, which is expected to witness the highest growth, largely due to improving medical facilities, growing awareness, and increasing focus of various players in this region.The report provides information on the current scenario, market outlook on the basis of the products available, application and geography, and the future forecasts on all prominent segments of the industry till 2020.

The report also provides details about innovative therapies that are now increasingly available in the market, as alternatives to the conventional PAP–based therapy. The later part of the report focuses on competitive analysis of the key market players, in terms of their market share and their product offerings. Major players operating in this market include Philips Respironics, ResMed, Fisher, and Paykel, among others. The competitive analysis is done at each player level, including their recent developments. To provide a thorough understanding of each player’s business model, the player’s current and historical financials have been analysed. On the whole, the study included in the report provides a detailed market overview, current and future scenario, and industry trends, which will likely generate key interest in investors thinking about joining the industry.

【レポートの目次】

1. Analyst View
2. Research Methodology
3. Sleep Apnea – An Introduction
4. Market Dynamics
4.1 Drivers
4.1.1 Increasing Prevalence of Sleep Related Breathing Disorders (SBD)
4.1.2 Growing Awareness of Sleep Apnea
4.1.3 Increasing Investment in Sleep Apnea Market
4.1.4 Technological Advancements
4.1.5 Rising Incidence of Obesity
4.2 Challenges
4.2.1 Poor Patient Compliance with CPAP Devices
4.3 Opportunities
4.3.1 Emerging Market Offering Significant Growth Opportunity
4.3.2 Colossal Undiagnosed Sleep Apnea Patient Pool
5. Sleep Apnea Therapeutic Devices Market Market Overview
5.1 Current Market Size and Future Growth
6. Sleep Apnea Therapeutic Devices Market, By Product
6.1 Introduction
6.1.1 Positive Airway Pressure Devices
6.1.1.1 Continuous Positive Airway Pressure Devices
6.1.1.2 Bilevel Positive Airway Pressure Devices
6.1.1.3 Auto Positive Airway Pressure Devices
6.1.1.4 Adaptive Servo – Ventillation Devices
6.1.2 Facial Interfaces
6.1.2.1 Nasal Masks
6.1.2.2 Nasal Pillow Masks
6.1.2.3 Full Face Masks
6.1.2.4 Others
6.1.3 Oral Appliances
6.1.3.1 Mandibular Advancement Devices
6.1.3.2 Tongue Retaining Devices
6.1.4 Accessories
6.1.4.1 Mask Accessories
6.1.4.2 Device Accessories
7. Sleep Apnea Therapeutic Devices Market, By Application
7.1 Introduction
7.1.1 Obstructive Sleep Apnea
7.1.2 Central Sleep Apnea
7.1.3 Complex/Mixed Sleep Apnea
8. Sleep Apnea Therapeutic Devices Market, By Region
8.1 Introduction
8.1.1 North America
8.1.2 Europe
8.1.3 Asia Pacific
9. Innovative Therapies for Sleep Apnea
9.1 Neurostimulators
9.2 Intra – Oral Devices
9.3 Others
10. Porter’s Five Forces Analysis
11. Competitive Analysis
11.1 Competitive Benchmarking
11.2 Market Share Assesment
12. Key Player Analysis
12.1 BMC Medical Co., Ltd.
12.2 CareFusion Corporation (A Subsidiary of Becton, Dickinson And Company)
12.3 Drive DeVilbiss Healthcare
12.4 Fisher & Paykel Healthcare Corporation Limited
12.5 Philips Healthcare (A Division of Koninklijke Philips N.V.)
12.6 ResMed Inc.
12.7 SomnoMed
12.8 Weinmann Geräte für Medizin GmbH + Co. KG
12.9 Whole You, Inc. (A Subsidiary of Mitsui Chemicals)

List of Figures:

Figure 3-1: Prevalance of Sleep Apnea in Comorbidities
Figure 5-1: Global – Sleep Apnea Therapeutic Devices Market (Million US$), 2015-2020
Figure 6-1: Global – Sleep Apnea Therapeutic Devices Market by Product (%), 2015
Figure 6-3: Global – PAP Devices Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-4: Global – CPAP Devices Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-5: Global – BiPAP Devices Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-6: Global – APAP Devices Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-7: Global – ASV Devices Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-8: Global – Facial Interfaces Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-9: Global – Nasal Masks Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-10: Global – Nasal Pillow Masks Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-11: Global – Full Face Masks Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-12: Global – Other Masks Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-13: Global – Oral Appliances Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-14: Global – Mandibular Advancement Devices Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-15: Global – Tongue Retaining Devices Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-16: Global – Accessories Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-17: Global – Mask Accessories Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-18: Global – Device Accessories Market for Sleep Apnea (Million US$), 2015-2020
Figure 7-1: Global – Sleep Apnea Therapeutic Devices Market by Application (%), 2015
Figure 7-3: Global – OSA Market (Million US$), 2015-2020
Figure 7-4: Global – CSA Market (Million US$), 2015-2020
Figure 7-5: Global – Complex Sleep Apnea (Million US$), 2015-2020
Figure 8-1: Global – Sleep Apnea Therapeutic Devices Market by Region (%), 2015
Figure 8-3: North America – Sleep Apnea Therapeutic Devices Market (Million US$), 2015-2020
Figure 8-4: Europe – Sleep Apnea Therapeutic Devices Market (Million US$), 2015-2020
Figure 8-5: Asia Pacific – Sleep Apnea Therapeutic Devices Market (Million US$), 2015-2020
Figure 10-1: Porter’s Five Forces Analysis
Figure 11-1: Global – Market Share Assesment for Key Players (%)
Figure12-1: Fisher & Paykel Healthcare Corporation Limited – Break up of Revenue by Product Group (%), 2015
Figure 12-2: Philips Healthcare – Break up of Revenue by Reportable Business Segment (%), 2014

List of Tables:

Table 6-1: Global – Sleep Apnea Therapeutic Devices Market by Product (Million US$), 2015
Table 7-1: Global – Sleep Apnea Therapeutic Devices Market by Application (Million US$), 2015
Table 8-1: Global – Sleep Apnea Therapeutic Devices Market by Region (Million US$), 2015
Table 11-1: Competitive Benchmarking
Table 12-1: Becton, Dickinson and Company – Key Financials (Million US$), 2012-2014
Table 12-2: Fisher & Paykel Healthcare Corporation Limited – Key Financials (Million US$), 2013-2015
Table 12-3: Koninklijke Philips N.V. – Key Financials (Million US$), 2012-2014
Table 12-4: ResMed Inc. – Key Financials (Million US$), 2013-2015
Table 12-5: Somnomed – Key Financials (Million US$), 2013-2015
Table 12-6: Mitsui Chemicals – Key Financials (Million US$), 2012-2014



【レポートのキーワード】

睡眠時無呼吸症候群

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の睡眠時無呼吸症候群治療市場動向(~2020)(Global Sleep Apnea Market Outlook 2020)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆